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 2012 Elsevier Inc. Open access under the ElseviThe reports regarding the mutual inﬂuence between the central nervous system and the immune system
constitute a vast and somewhat controversial body of literature. Stress is known to disturb homeostasis,
impairing immunological functions. In this study, we investigated the hematopoietic response of Chlorella
vulgaris (CV)-treated mice exposed to single (SST) and repeated stress (RST). We observed a reduction in
the numbers of hematopoietic progenitors (HP) in the bone marrow and long-term bone marrow cultures
(LTBMC) using ﬂow cytometry and a coinciding decrease in the number of granulocyte–macrophage col-
onies (CFU-GM) after treatment with both stressors, but SST caused a more profound suppression. We
observed a proportional increase in the colony-stimulating activity (CSA) of the serum of animals sub-
jected to SST or RST. In the bone marrow, SST and RST induced a decrease in both mature myeloid and
lymphoid populations but did not affect pluripotent hematopoietic progenitors (LinSca-1+c-kit+, LSK),
and again, a more profound suppression was observed after SST. We further quantiﬁed the levels of inter-
leukin-1a (IL-1a) and interleukin-6 (IL-6) and the number of myeloid cells in LTBMC. Both SST and RST
reduced the levels of these cytokines to similar degrees. The myeloid population was also reduced in
LTBMC, and SST induced a more intense suppression. Importantly, CV treatment prevented the changes
produced by SST and RST in all of the parameters evaluated. Together, our results suggest that CV treat-
ment is an effective tool for the prophylaxis of myelosuppression caused by single or repeated stressors.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Interdisciplinary collaboration has established psychoneuroim-
munology, also known as neuroimmunomodulation, as a ﬁeld of
investigation with the goal of rigorous scientiﬁc research into the
elusive mind–body connection. The neuroendocrine system is
capable of modulating the immune system via a wide breadth of
control mechanisms that link these two systems (Blalock, 1994).
Evidence for this interaction is derived from the observation that
certain neurotransmitters, neuropeptides, and neurohormones af-
fect the immune function both in vivo and in vitro, and receptors
for these molecules are present on lymphocytes and macrophages
(Alves et al., 2007; Blalock, 1989; Carvalho-Freitas et al., 2008;
Costa-Pinto and Palermo-Neto, 2010; Downing and Miyan, 2000;cada e Toxicologia, Faculdade
de São Paulo, Rua Prof. Dr.
Paulo, SP, Brazil. Tel.: +55 11
).
er OA license.Nance and Sanders, 2007; Quinteiro-Filho et al., 2012). Since the
1936 studies by Selye (1936), stress induction has been considered
a promising method to study the interactions between the nervous
and immune systems. Psychological stressors, such as conﬁnement
or predator odors, as well as physical stressors, such as low tem-
perature or food shortage, evoke physiological changes that disturb
homeostasis by altering the equilibrium of various humoral fac-
tors. These factors in turn have a signiﬁcant impact on the immune
response in general (Alves et al., 2007; Besedovsky and Del Rey,
1996; Carvalho-Freitas et al., 2008; Chrousos, 2000; Quinteiro-
Filho et al., 2012). Exposing animals to stressful situations activates
the hypothalamic–pituitary–adrenal (HPA) axis and the release of
glucocorticoids and catecholamines into the blood (Armario
et al., 2012; Black, 1994; Blalock, 1994; Dunn, 1995; Glaser and
Kiecolt-Glaser, 2005; Stratakis and Chrousos, 1995).
A wide array of physical and psychological stressors alters
immunity, and both the qualitative and quantitative features of
these stressors markedly inﬂuence the immune response. Many
differences exist in the ways that short-term and long-term stress-
ors affect physiology and behavior (Dhabhar and McEwen, 1997).
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by stressors, particularly macrophage activity (Silberman et al.,
2003; Palermo-Neto et al., 2003), antibody production (Karp
et al., 2000), and sensitivity to the antigen 2,4-dinitro-1-ﬂuoroben-
zene (DNFB) (Blecha et al., 1982).
Evidence has demonstrated that the nervous system has an
important role in the regulation of blood cell production and the
selective release of these cells from the bone marrow into the cir-
culation (Afan et al., 1997; Broome et al., 2000; Dhabhar et al.,
1995; Maestroni, 2000). Many humoral factors are able to inﬂu-
ence the survival, proliferation, and differentiation of the multipo-
tent stem cell and its progeny under stress conditions. In this
regard, studies from our laboratory (Malacrida et al., 1997a,b;
Souza-Queiroz et al., 2004, 2008) and others (Broome et al.,
2000; Dugan et al., 2007; Dygai et al., 1991; Goldberg et al.,
1988; Mizobe et al., 1997) have demonstrated hematopoietic alter-
ations after exposure to different experimental models of stressors.
Hematopoiesis is initiated by a rare population of bone marrow
(BM)–resident multipotent hematopoietic stem cells (HSC) that are
faced at each cell division with the decision to self-renew, differen-
tiate, migrate, or die (Domen andWeissman, 1999). During steady-
state hematopoiesis, the HSC population is relatively quiescent, but
they give rise, upon cell cycle entry, to a hierarchy of differentiat-
ing progenitor populations that undergo the massive proliferative
expansion required to replenish the blood system. HSC are recog-
nized to be positive for c-kit, Sca-1 and Thy1.1 and negative for
the mature lineage markers (Lin) and FLK2 (Passagué et al.,
2005). The HSC-containing LinSca-1+c-Kit+ (LSK) cell population
is able to self-renew and differentiate into a hematopoietic progen-
itor population (LinSca-1c-Kit+, HP) that lacks the ability to
reconstitute lethally irradiated mice (Peng et al., 2012). Lineage-
speciﬁc surface antigens such as Gr-1+ and Mac-1+ (Lin+) are
known to characterize dedicated myeloid lineage cells (Larsson
and Karlsson, 2005), and B220+ and CD3+ have been reported to
mark B and T lymphocytes, respectively (Salva et al., 2012).
Long-term bone marrow cultures (LTBMC) appear to embody
many of the features of hematopoietic cell regulation in vivo, and
they closely resemble the environment of hematopoietic tissues
(Dexter, 1979; Daniel et al., 1989). Ex vivo studies have shown that
cells of the adherent layer, either spontaneously or after activation,
produce a number of positive soluble factors capable of promoting
the maintenance, survival, proliferation, differentiation and exten-
sive cell renewal of hematopoietic cells (Eaves et al., 1991; Fibbe
et al., 1988; Herman et al., 1998). Some endogenous positive
regulators, such as stem cell factor, IL-6, IL-11, IL-12, and colony-
stimulating factors (CSF), among others, are involved in regulating
the proliferative activity of primitive hematopoietic cells in LTBMC
(Eaves et al., 1991). The fact that hematopoiesis can be maintained
for several weeks (Gartner and Kaplan, 1980) makes LTBMC an
ideal model for investigating the modulating effects of new com-
pounds on disorders of the hematopoietic tissues.
Chlorella vulgaris (CV) is a microscopic single-celled freshwater
green algae that is considered to be a biological response modiﬁer,
as demonstrated by its protective activities against viral and bacte-
rial infections in normal and immunosuppressed mice (Dantas and
Queiroz, 1999; Hasegawa et al., 1994, 1995; Queiroz et al., 2003;
Tanaka et al., 1986) and against tumors (Justo et al., 2001; Konishi
et al., 1985; Tanaka et al., 1984, 1998). It is reported to be a rich
source of antioxidants, such as lutein, a- and b- carotene, ascorbic
acid and tocopherol, and it supplies large quantities of vitamins,
minerals and dietary ﬁber (Gurer and Ercal, 2000; Rodriguez-
Garcia and Guil-Guerrero, 2008; Vijayavel et al., 2007). Notably,
CV stimulates the pool of hematopoietic stem cells and activates
leukocytes, important aspects of CV-mediated modulation of the
immune system of immunosuppressed hosts (Hasegawa et al.,
1990; Konishi et al., 1990, 1996). Studies from our laboratory havedemonstrated that CV signiﬁcantly prevents the reduced capacity
of HP to form granulocyte–macrophage colonies (CFU-GM) ob-
served in tumor-bearing, stressed and infected mice (Dantas and
Queiroz, 1999; Justo et al., 2001; Queiroz et al., 2003; Souza-
Queiroz et al., 2004, 2008).
To further understand the inﬂuence of CV on hematopoiesis, we
quantiﬁed hematopoietic populations in the bone marrow of mice
subjected to a single or repeated stressor using ﬂow cytometry and
assessed the clonogenic capacity of myeloid cells to form CFU-GM
in vivo (bone marrow) and ex vivo (LTBMC). LTBMC provided infor-
mation about the impact of both stressors on functional activity
from the medullar stroma and its ability to interact with hemato-
poietic cells. IL-6 and IL-1a, important hematopoietic regulators,
were measured in the cultures. The colony-stimulating activity of
the serum (CSA) from these mice provided information about the
amount of CSF present in the blood after single and repeated
stressors.2. Materials and methods
2.1. Mice
Male BALB/c mice, 6–8 weeks old, were bred at the Campinas
University Central Animal Facilities (Centro de Bioterismo, Univer-
sidade Estadual de Campinas, Campinas, SP), raised under speciﬁc
pathogen-free conditions, and matched for body weight before use.
Standard chow and water were freely available. Animal experi-
ments were performed in accordance with institutional protocols
and the guidelines of the Institutional Animal Care and Use Com-
mittee (Protocol Number 1997-1), which follow the recommenda-
tions of the Canadian Council on Animal Care (Olfert et al., 1993).
The animals were divided into 6 groups of 6 animals each: Controls
(C – gavage with vehicle (warm water) for 5 days before bone mar-
row removal); C. vulgaris (CV – received CV for 5 days before bone
marrow removal); single stress/CV + single stress (SST/CV + SST –
received vehicle or CV for 5 days before stress protocol); repeated
stress/CV + repeated stress (RST/CV + RST – received vehicle or CV
for 21 days, i.e., throughout the stress protocol). All experiments
were replicated twice.
2.2. Stress model
Single stress consisted of a single 3-h session of restraint stress.
Repeated stress consisted of 21 daily sessions that were 2 h each.
Restraint stress was performed in plastic 50 mL conical falcon
tubes. A hole was made at one extremity of the tubes for the tail
of the mouse, and another hole was made in the other extremity
to enable the mice to breathe. The animals received no food or
water during the stress protocol. After being placed into the tubes,
the animals were returned to their home cages inside their room.
In all groups, femoral marrowwas collected 2 h after either the sin-
gle or the ﬁnal repeated stress applications.
2.3. Treatment regimens
Dried CV algae, a unicellular green algae strain, were kindly pro-
vided by Dr. Hasegawa (Research Laboratories, Chlorella Industry
Co. Ltd., Fukuoka, Japan). Chemical analysis performed by Hase-
gawa et al. (1990) revealed that CV contains 44.4 g of protein,
39.5 g of carbohydrates and 15.4 g of nucleic acid in 100 g (dry
weight) of whole material. No lipids were detected. CV was pre-
pared in distilled water, and a dosage of 50 mg/kg was given orally
by gavage in a 0.2 mL volume/mouse for 5 consecutive days before
single stress or for the entire period of repeated stress. The selec-
tion of doses for CV was based on previous studies performed in
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1999; Queiroz et al., 2008). In all groups, femoral marrow was col-
lected 24 h after the ﬁnal administration of CV.
2.4. Progenitor cell assays
Assays for CFU-GM were performed using bone marrow cells
and non-adherent cells collected from LTBMC. The plug of marrow
cells was gently extruded into a sterile plastic tube using 1 mL of
RPMI medium injected through the femur and then converted to
a dispersed cell suspension in 5 mL of RPMI by gently aspirating
the suspension up and down 20 times using a sterile 5 mL pipette.
The bone marrow cells were placed in duplicate 1 mL semisolid
agar cultures in 35 mm Petri dishes using 1  105 bone marrow
cells per culture for the growth of CFU-GM. The cells were cultured
in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM, Sigma Chemical
Co., St. Louis, MO) containing 20% FCS (fetal calf serum) and 0.3%
agar. Colony formation was stimulated by the addition of recombi-
nant murine macrophage–granulocyte colony-stimulating factor
(rmGM-CSF-Sigma) at a ﬁnal concentration of 0.5 ng/mL. The cul-
tures were incubated for 7 days in a fully humidiﬁed atmosphere
of 5% CO2 in air, and colony formation (clones >50 cells) was scored
at 35 magniﬁcation using a dissection microscope (Metcalf,
1984).
2.5. Flow cytometric analysis
To evaluate the hematopoietic cell populations, whole BM and
LTBMC cells were collected by ﬂushing (1  106 cells), ﬁxed and la-
beled. To the veriﬁcation of mature cells we used 4 antibodies con-
jugated with four different ﬂuorocromes: FL1: anti-Gr1-FITC; FL2:
anti B220-PE, FL-3:anti-Mac-1-Cy7/PE and FL4: anti-CD3-APC. To
analyze the primitive population we used 2 antibodies that recog-
nize the fraction LSK together with a cocktail of mature lineage:
FL2: anti-B220, anti-CD3, anti-Ter-119, anti-CD11b and anti-Gr-1,
which were all conjugated with PE; FL3: anti Sca-1-Cy7/PE and
FL4: anti-c-kit-APC. The data were collected using a FACSCalibur
ﬂow cytometer and analyzed using CellQuest software (BD Biosci-
ences). The antibodies were purchased from BD Biosciences.
2.6. Assay for serum colony-stimulating activity
The mice were bled from the heart under deep halothane anes-
thesia. Within each experimental group, the blood was pooled, left
at 37 C for 30 min, and the clots were allowed to retract overnight
at 4 C. Following centrifugation, the serum was removed and
stored at 20 C. CSA was determined by measuring the ability
of serum obtained from control and experimental groups to stim-
ulate HP to form CFU-GM (1  105 cells) from normal mice. The re-
sults were expressed as units of CSA/mL, where 1 unit/mL was
deﬁned as the lowest amount of CSA able to induce the formation
of colonies (Van Den Engh and Bol, 1975).
2.7. Long-term bone marrow cultures (LTBMC)
Marrow cells were aseptically collected from two complete fe-
mur shafts after killing the animal by cervical dislocation. The plug
of marrow cells was gently extruded into a sterile plastic tube
using 1 mL of RPMI 1640 medium (Sigma) injected through the fe-
mur and then converted to a dispersed cell suspension in 5 mL of
RPMI by gently aspirating the suspension up and down 20 times
using a sterile 5 mL pipette. To establish the culture, 1  107
pooled femoral bone marrow cells were dispensed into T25 tissue
culture ﬂasks containing 10 mL of RPMI 1640 supplemented with
25 mM L-glutamine, 25 mM HEPES, 200 UI/mL penicillin, 100 lg/
mL streptomycin, 20% horse serum (Sigma), and 0.1 lM hydrocor-tisone and incubated at 37 C in 5% CO2. At 7-day intervals, the cul-
tures were fed by removing half the growth medium (5 mL) and
adding an equal volume of fresh growth medium. On the fourth
week, the bone marrow cultures were recharged (fed as before,
with 5 mL of growth medium containing a further 1  107 freshly
isolated syngeneic femoral bone marrow cells from comparably
aged mice as described by Gartner and Kaplan, 1980). Supernatants
from LTBMC were harvested weekly from the 5th to 9th week of
culture and frozen at 20 C until required. The pooled cell suspen-
sions were counted in a hemocytometer and centrifuged at 800g
for 10 min, and the clonal growth of non-adherent progenitor cell
populations was assayed weekly, as described in Section 2.4.
2.8. Quantiﬁcation of cytokine levels
The concentrations of IL-1a and IL-6 were evaluated in the
supernatant of LTBMC. Cytokines were quantiﬁed using a sandwich
ELISA (Enzyme-Linked Immunosorbent Assay) in microtiter plates
(96-well ﬂat-bottom maxisorp microplate-NUNC, Roskilde, DM)
using the following monoclonal antibodies purchased from R&D
Systems: DuoSet ELISA Development System Kit with puriﬁed
anti-mouse IL-6 (Cat. DY406) and anti-mouse IL-1a/IL-1F1 (Cat.
DY40). The cytokine levels were determined according to the
R&D Systems cytokine ELISA protocol. Cytokine titers were ex-
pressed in pg per mL and were calculated by reference to standard
curves constructed with known amounts of recombinant
cytokines.
2.9. Statistical analysis
For statistical analysis of changes in the progenitor cell assays,
immunophenotyping, cytokine levels and colony-stimulating
activity, analysis of variance (ANOVA – two way) followed by the
Bonferroni test was used to compare data among all groups. Statis-
tical signiﬁcance was reached when P < 0.05.3. Results
3.1. CV modulates the clonogenic capacity of primitive cells to form
CFU-GM in mice subjected to single or repeated stressors
The effects of CV treatment on the number of bone marrow
CFU-GM in animals subjected to SST or RST is demonstrated in
Fig. 1A. The application of either SST or RST caused a signiﬁcant
reduction in CFU-GM (CTR: 18 ± 2  103, SST: 5 ± 1.5  103 and
RST: 10 ± 1.5  103, P < 0.05). This reduction was higher in animals
subjected to SST (SST: 5 ± 1.5  103 and RST: 10 ± 1.5  103,
P < 0.05). The oral administration of 50 mg/kg of CV prevented
the CFU-GM decrease in mice subjected to stressors, keeping
CFU-GM numbers similar to control levels. CV treatment alone pro-
duced no changes in the number of CFU-GM in the bone marrow of
normal mice.
3.2. CV promotes expansion of the primitive and mature hematopoietic
populations in bone marrow
The effects of oral CV treatment were also evaluated on mature
myeloid populations in animals subjected to both conditions
(Fig. 1B). The percentage of Gr-1+Mac-1+ cells was reduced after
SST and RST (CTR: 37 ± 3%, SST: 23 ± 1% and RST: 29 ± 2%,
P < 0.05) with higher suppression after SST (23 ± 1%, P < 0.05). CV
treatment prevented the changes induced by SST and RST on the
Gr-1+Mac-1+ population, maintaining levels similar to those of
the control group (CV + SST: 36 ± 2%, CV + RST: 41 ± 2% and CTR:
37 ± 3%). Representative histogram is demonstrated in Fig. 1C.
Fig. 1. (A) Number of granulocyte–macrophage progenitor colonies (CFU-GM), (B) quantiﬁcation of mature myeloid cells (Gr1+Mac1+) and (C) representative original images
from ﬂow cytometric analysis of myeloid cells in mice treated orally with CV at 50 mg/kg/day for 5 days prior to SST or, concomitantly, to RST (21 days). The mice were
sacriﬁced 24 h after the last treatment. Control mice received diluent only. The results represent the means ± SD of six mice per group. ⁄P < 0.05 vs. control; %P < 0.05 vs. RST;
#P < 0.05 vs. SST; @P < 0.05 vs. RST.
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in B220+ (B lymphocyte) and CD3+ (T lymphocyte) lymphoid pop-
ulations. Both stressors decreased the percentage of B cells (CTR:
41 ± 1%, SST: 15 ± 1% and RST: 22%, P < 0.05), but the single stress
event caused a more intense suppression (15 ± 1%, P < 0.05)
(Fig. 2A). The number of T cells was also altered during stress
(CTR: 1,1 ± 0.1%, SST: 0,4 ± 0.1% and RST: 0.7 ± 0.1%, P < 0.05). Sim-
ilar results were observed in the lymphoid population following CV
pretreatment as in myeloid populations, with the pool of cells
retaining numbers similar to those seen in controls (CV + SST:
1.1,3 ± 0.1%, CV + RST: 1,2.1 ± 0.1% and C: 1 ± 0.1%) (Fig. 2B). Repre-
sentative histogram is demonstrated in Fig. 2C.
We also investigated the potential for CV modulation of primi-
tive hematopoietic cells. The LSK cells (LinSca1+c-Kit+) were not
altered in these animals (Fig. 3A), but the total number of hemato-
poietic progenitor cells (HP: LinSca1c-kit+) was reduced by both
stressors (CTR: 0.5% ± 0.007, SST: 0.2% ± 0.001 and RST:0.3% ± 0.003, P < 0.05). Again, the single stress event induced a
more robust suppression (0.2% ± 0.001, P < 0.05). CV treatment pre-
vented the changes induced by SST and RST in the number of HP,
maintaining levels similar to those observed in control animals
(CV + SST: 0.5% ± 0.005, CV + RST: 0.5% ± 0.004 and CTR:
0.5% ± 0.007) (Fig. 3B). Representative histogram is demonstrated
in Fig. 3C.
3.3. Serum colony-stimulating activity
The effect of oral CV treatment on serum CSA in stressed ani-
mals is shown in Fig. 4. The application of both types of stressors
led to a signiﬁcant increase in CSA (P < 0.05), with levels reaching
amounts 3.5-fold higher in RST animals and 7-fold higher in SST
animals compared with control mice. The treatment of these ani-
mals with CV further increased CSA by 26% (CV + SST) and 57%
(CV + RST) (P < 0.05 vs. stressed controls). The treatment of
Fig. 2. Quantiﬁcation of (A) B lymphocytes (B220+) and (B) T lymphocytes (CD3+) in the bone marrow of mice treated orally with CV at 50 mg/kg/day for 5 days prior to SST or,
concomitantly, to RST (21 days). The mice were sacriﬁced 24 h after the ﬁnal treatment. Control mice received diluent only. (C) Representative original images from ﬂow
cytometric analysis of B and T lymphocytes. The results represent the means ± SD of six mice per group. ⁄P < 0.05 in relation to control; %P < 0.05 vs. RST; #P < 0.05 in relation
to SST; @P < 0.05 in relation to RST.
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creases (2-fold) in CSA levels (P < 0.05).3.4. Long-term bone marrow culture
3.4.1. Pretreatment with CV prevented the suppressive effect promoted
by both types of stressors on CFU-GM
The number of bone marrow CFU-GM in the supernatant of
LTBMC is presented in Fig. 5. In the ﬁfth week of culture, peak
numbers of CFU-GM were produced in all groups as a consequence
of repopulation. In SST and RST groups, the crucial feature observed
in the cultures was the reduced capacity of cultured cells to sup-
port the growth and differentiation of CFU-GM at all time-points
evaluated. SST produced a more severe reduction in CFU-GM than
RST (P < 0.05), with SST reaching levels as low as a 3-fold decreasewhile RST reached levels as low as a 1.6-fold decrease in the 7th
week of culture. However, when these animals were treated with
CV, the CFU-GM numbers were maintained at control levels in all
time-points studied. No signiﬁcant changes were observed in CV-
treated non-stressed mice. (Fig. 5A). Fig. 5B shows representative
original pictures from the cultures.3.4.2. CV promotes expansion of the primitive and mature
hematopoietic populations in LTBMC
The effects of oral CV treatment on mature myeloid cell popula-
tions (Gr1+Mac1+) and the number of HP (Linc-Kit+Sca1) in the
LTBMC of animals subjected to SST and RST are shown in Fig. 6.
We observed that both stressors decreased the percentage of Gr-
1+Mac-1+ cells (CTR: 25 ± 1%, SST: 14 ± 2% and RST: 19 ± 1.8%,
P < 0.05) (Fig. 6A). The HP number was also altered in this system
Fig. 3. (A) Gating strategy for analyzing the primitive murine hematopoietic population. (B) Quantiﬁcation of LSK cells and (C) hematopoietic progenitors (HP) in the bone
marrow of mice orally treated with CV at 50 mg/kg/day for 5 days prior to SST or, concomitantly, to RST (21 days). The mice were sacriﬁced 24 h after the last treatment.
Control mice received diluent only. (C) Representative original images from ﬂow cytometric analysis of LSK and HP cells. The results represent the means ± SD of six per
group. ⁄P < 0.05 vs. control; %P < 0.05 vs. RST; #P < 0.05 vs. SST; @P < 0.05 vs. RST.
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treatment prevented the changes induced by SST and RST in the
number of HP and Gr1+Mac1+, maintaining levels similar to those
observed in control animals (Fig. 6A and B). Representative histo-
gram is demonstrated in Figs. 6C and 6D.3.4.3. CV induces increase in the levels of the myelocytokines IL-1a and
IL-6 in LTBMC
The levels of IL-1a and IL-6 were measured weekly (6–9 weeks)
in the supernatants of LTBMC. As shown in Figs. 7 and 8, a progres-
sive decline was observed in the levels of both cytokines in all
groups studied. However, SST and RST further reduced the produc-
tion of IL-1a (Fig. 7 A and B) and IL-6 (Fig. 8 A and B) when com-
pared with controls (P < 0.05). Treatment of stressed animals
with CV prevented the decrease in the production of both cyto-
kines to control levels (P < 0.05). These results are consistent withthe increased ability of the stromal cell layer to display CFU-GM
in vitro (item 3.4.1). Notably, treatment of non-stressed mice with
CV caused a 15% increase in the levels of both cytokines.4. Discussion
Because a variety of stressors may compromise the physiologi-
cal role of the hematopoietic system in sustaining the proliferation
and differentiation of progenitor cells to fulﬁll the continual cellu-
lar demands of the organism, we compared the impact caused by a
single stressor (SST) or a repeated stressor (RST) on several param-
eters of the hematopoietic response in mice treated with CV using
both in vivo and ex vivo systems. To our knowledge, this is the ﬁrst
study to compare the effects of a single or repeated application of
an emotional stressor on the bone marrow (BM) and the functional
activity of marrow stroma (measured by LTBMC). The latter is of
Fig. 4. Colony stimulating activity (CSA) from the serum of mice treated orally with
CV at 50 mg/kg/day for 5 days prior to SST or, concomitantly, to RST (21 days). The
mice were sacriﬁced 24 h after the last treatment. Control mice received diluent
only. The results represent the means ± SD of six mice per group. ⁄P < 0.05 vs.
control; %P < 0.01 vs. RST; #P < 0.05 vs. SST; @P < 0.05 vs. RST.
Fig. 5. (A) Number of granulocyte–macrophage progenitor colonies (CFU-GM) collected
by gavage with 50 mg/kg of CV for 5 days prior to SST or, concomitantly, to RST (21 day
marrow cells were inoculated into ﬂat-bottomed ﬂasks in 10 mL of complete medium to
growth medium and adding an equal volume of fresh growth medium. After 4 weeks, th
were stimulated by rmGM-CSF for the CFU-GM assays. The results indicate the means ± S
@P < 0.05 vs. RST. (B) Microscopic aspect of LTBMC. (a) Control group, (b) stressed group, (c
of 20.
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ports blood and immunocompetent cell generation (Dorschkind,
1990).
Our results showed a reduced number of hematopoietic progen-
itors (HP) from animals subjected to SST and RST, which corre-
sponded with decreased CFU-GM numbers in both the BM and
the LTBMC. In this case, SST induced a stronger suppression. We
also measured the serum levels of colony-stimulating factors from
plasma (CSA) and observed a signiﬁcant increase after both stress-
ors, inﬂuencing the proliferation and differentiation of BM-derived
phagocytes. Persistent elevation of CSA levels during stress events
serves as a continuing stimulus that supports the survival, prolifer-
ation, differentiation, and end functional activity of granulocytes
and monocytes (Cheers et al., 1988; Guleria and Pollard, 2001;
Kayashima et al., 1993; Wing et al., 1985; Zhan et al., 1998). Treat-
ment with CV produced a further increase in CSA levels in the BM
of stressed mice (both SST and RST) and restored the number of
HPs from BM and LTBMC to control levels. Concurrently, the reduc-
tion of CFU-GM numbers from BM and LTBMC induced by the
stressors was prevented by the treatment with CV.weekly from LTBMC supernatant. In all treatment schedules, the mice were treated
s). The mice were sacriﬁced 24 h after the last treatment, and 1  107 pooled bone
establish LTBMC. At 7-day intervals, the cultures were fed by removing half of the
e cultures were recharged. Non-adherent cell suspensions of 1  105 marrow cells
D of 3 culture ﬂasks/group. ⁄P < 0.05 vs. control; %P < 0.05 vs. RST; #P < 0.05 vs. SST;
) single or repeated stress + pre-treatment with 50 mg/kg Chlorella vulgaris. Increase
Fig. 6. Quantiﬁcation of (A) myeloid cells (Gr1+Mac1+) and (B) hematopoietic progenitors (HP) from the LTBMC of mice treated orally with CV at 50 mg/kg/day for 5 days
prior to SST or, concomitantly, to RST (21 days). Representative original images from ﬂow cytometric analysis of (C) myeloid cells and (D) hematopoietic progenitors are
demonstrated. The mice were sacriﬁced 24 h after the last treatment. Control mice received diluent only. The results represent the means ± SD of six mice per group. ⁄P < 0.05
vs. control; %P < 0.05 vs. RST; #P < 0.05 vs. SST; @P < 0.05 vs. RST.
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Fig. 7. Levels of IL-1a collected weekly from the supernatant of LTBMC. Mice were
treated by gavage with CV at 50 mg/kg for 5 days prior to (A) SST or, concomitantly,
to (B) RST (21 days). The mice were sacriﬁced 24 h after the last treatment. Control
mice received diluent only. The results represent the means ± SD of six mice per
group. ⁄P < 0.05 vs. control.
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Fig. 8. Levels of IL-6 collected weekly from the supernatant of LTBMC. The mice
were treated by gavage with CV at 50 mg/kg for 5 days prior to (A) SST or,
concomitantly, to (B) RST (21 days). The mice were sacriﬁced 24 h after the last
treatment. Control mice received diluent only. The results represent the means ± SD
of six mice per group. ⁄P < 0.05 vs. control.
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1997, 2000) showing that CV treatment increased mRNA levels
for granulocyte–macrophage colony-stimulating factor (GM-CSF).
This stimulus can be attributed to the presence of a glycoprotein,
which is puriﬁed from CV, is soluble in water and has been re-
ported to be a hematopoietic stimulator that increases CSF levels
and promotes progenitor cell migration from the bone marrow to
the spleen followed by an expansion of CFU-GM in this organ after
chemotherapy (Konishi et al., 1996). The presence of a-tocopherol
in CV, the former of which is a member of the vitamin E family and
possesses numerous biological properties including signiﬁcant ef-
fects on inﬂammation, cell proliferation, and apoptosis (Azzi,
2007; Lemaire-Ewing et al., 2010; Singh et al., 2006), may also be
important here, as it has been shown to increase the number of
HP as demonstrated by CFU-GM assays in the bone marrow of irra-
diated mice after treatment (Bichay and Roy, 1986; Cherdyntseva
et al., 2005; Roy et al., 1982). The presence of these components
in CV can explain, in part, the fact that we observed a small but sig-
niﬁcant increase in CSA in the BM of non-stressed animals after CV
treatment; however, this increase did not interfere with the num-
ber of HP or with the CFU-GM.
The reduced capacity of cultured cells to support the growth
and differentiation of CFU-GM following the application of SST
or RST was consistent throughout the duration of the cultures
(7 weeks), and the suppression caused by SST was more severe
until the 7th week. From the 1st to the 4th weeks of culture,
the stromal layer is formed in the ﬂasks. In the 5th week, the
cultures are repopulated with cells from the respective groups
of mice. These cells interact with the stroma, demonstrating
their capability to maintain hematopoiesis. Therefore, we pro-pose that SST and RST directly interfere with the physical con-
tacts between stromal and hematopoietic cells. This hypothesis
is in agreement with a signiﬁcant reduction in the local produc-
tion of IL-6 and IL-1a by stromal cells after stressor application,
as observed in this study. IL-6 plays a critical role in the gener-
ation and maintenance of myelopoiesis in murine LTBMC (Haus-
er et al., 1997) and is a survival factor for hematopoietic stem
cells (Bernard et al., 1994). Both IL-6 and IL-1a have synergistic
activity with CSFs in stimulating hematopoiesis, thus contribut-
ing to the maintenance of neutrophil maturation and viability
(Eaves et al., 1991; Dinarello, 1996; Muench et al., 1992). Stud-
ies in the literature demonstrate that IL-1a accelerates both
granulopoietic and thrombopoietic recovery in 5-ﬂuorouracil
myelosuppressed mice (Kovacs et al., 1997). However, in con-
trast to what we observed with HP and CFU-GM numbers, the
decrease caused by SST and RST on the levels of these cytokines
was of equal magnitude. Thus, the modulation of other impor-
tant environmental regulators by SST is responsible for causing
the increased suppression of HP and CFU-GM. IL-3 is also a sig-
niﬁcant cytokine during hematopoiesis, and it participates in
the host response to various types of stressors (Bessler et al.,
2000). Treatment with CV increased the ability of stromal cells
from stressed animals to produce IL-6 and IL-1a, which is con-
sistent with the increased numbers of HP and the increased
ability of the stromal cell layer to support CFU-GM ex vivo.
Almost all immune cells have receptors for one or more of the
hormones associated with HPA and SNAS activation (Black, 1994;
Glaser and Kiecolt-Glaser, 2005; Heyworth et al., 1992; Miyan
et al., 1998; Spiegel et al., 2007). To further understand the effects
of CV treatment on the hematopoiesis of animals subjected to SST
or RST, we evaluated the mature cell populations from bone mar-
row and LTBMC samples. Both stressors had a suppressive effect
on lymphoid lineage cells (B and T cells) in the BM, with a more
signiﬁcant suppression after SST. The reduction in the number of
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hallmark of the stress response (Edgar et al., 2003; Souza-Queiroz
et al., 2008). Elevated glucocorticoids lead to rapid apoptotic loss of
lymphoid cells both peripherally and in the bone marrow (Black,
1994). Mature myeloid cell population (Gr1+Mac1+) was also re-
duced after SST and RST in both the BM and LTBMC, with further
reductions in the SST group. Elevation of noradrenaline and adren-
aline levels may produce changes in lymphocyte, monocyte, and
leukocyte function (Dunn, 1990). The primitive hematopoietic
population (LSK) was also evaluated in the BM. No alteration in
the number of LSK cells was observed after stress, a fact that can
be explained, at least in part, by the fact that the blood-forming
system should be able to respond efﬁciently to hematological
stressors by expanding the LSK population, mainly through in-
creased self-renewing divisions (Morrison et al., 1997; Wright
et al., 2001). Thus, LSK proliferation must be highly adaptive to en-
sure durable production of progenitor populations during steady-
state hematopoiesis and extensive, stress-induced, self-renewal
proliferation without depleting the stem cell pool (Passagué
et al., 2005).
Relevant to our present ﬁndings is the fact that nerve ﬁbers
containing noradrenaline enter the hematopoietic tissue of bone
marrow and terminate at synapses on hematopoietic cells. They
promote negative regulation of hematopoietic activity, affecting
both hematopoiesis and the release of mature cells from the
marrow (Heyworth et al., 1992). These observations acquire
additional signiﬁcance in view of the fact that adrenoreceptors
are expressed on Th1 cells, but not Th2 cells (Sarders et al.,
1997; Elenkov et al., 2000), thus providing a mechanistic basis
for the differential effects on Th1/Th2 function. An increasing
body of evidence indicates that suppression of cellular immu-
nity through selective inhibition of Th1, in favor of Th2 re-
sponses, is an important feature of stress (Elenkov et al.,
1996, 2000; Woiciechowsky et al., 1998; Zhang et al., 2005;
Souza-Queiroz et al., 2008). B2-agonists inhibit IL-12 production(Panina-Bordignon et al., 1997), which is known to have a cen-
tral role in the immune system by skewing the immune re-
sponse towards Th1-type responses. In this respect, studies
from our laboratory and others (Hasegawa et al., 1997; Queiroz
et al., 2002, 2011; Souza-Queiroz et al., 2008; Torello et al.,
2010) have proposed that CV has a direct myelostimulating out-
come through inducing the Th1 response via activation of mac-
rophages to produce IL-12 and IFN-c. Previous ﬁndings from
our laboratory demonstrated that pre-treatment with CV pre-
vented this decrease in IFN-c (Th1) and increase in IL-10
(Th2) after an acute foot-shock stressor (Souza-Queiroz et al.,
2008). This reduction in IL-1 and TNF-a was prevented by treat-
ing mice with CV that were inoculated with tumors (Ramos
et al., 2010) or exposed to lead (Queiroz et al., 2008, 2011).
These cytokines are known to stimulate the production of neu-
trophils from the bone marrow and to mediate chemoattraction
of granulocytes from the circulation to peripheral sites of injury.
In the present study, we observed that the effects produced by
both single and repeated stressors were suppressive, however, SST
had a stronger impact on most of the parameters evaluated. This
could be explained by a decrease in hormone release due to glan-
dular exhaustion or down-regulation of receptors, among other
possibilities, or it could also be explained by a reduction in the
emotional impact initially caused by the stressful situation, thus
leading to a decreased endocrine response over time (Armario,
2001).
Delineating how stress inﬂuences hematopoiesis is important
for developing potential pharmacological interventions to decrease
the incidence of stress-induced immune dysfunction. Irrespective
of the mechanisms involved, the immunomodulatory effect of CV
on stressed mice may have an important role in protecting hosts
from stressful situations, leading to an increase in the ability of
the immune system to respond to this challenge (for an overview
of the mechanisms of action from CV on stressed mice observed
in this study, see Fig. 9).
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